Anti-T. Cruzi agents: Our experience in the evaluation of more than five hundred compounds

Mini-Reviews in Medicinal Chemistry

Volumn 8, Issue 13, 2008, Pages 1355-1383

  Cerecetto, Hugo ^a   González, Mercedes ^a  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

5 NITROFURYL DERIVATIVE; 5 NITROFURYLACROLEINE DERIVATIVE; 5 NITROTHIENYL DERIVATIVE; ANTIPARASITIC AGENT; BENZIMIDAZOLE N OXIDE DERIVATIVE; BENZOFUROXAN DERIVATIVE; BENZOFUROXANYL DERIVATIVE; FUROXANYL DERIVATIVE; INDAZOLE N OXIDE DERIVATIVE; N OXIDE DERIVATIVE; THIOSEMICARBAZONE INHIBITOR; UNCLASSIFIED DRUG; ANTITRYPANOSOMAL AGENT; HETEROCYCLIC COMPOUND; NITRO DERIVATIVE; ORGANOMETALLIC COMPOUND;

ALKYLATION; ANTIPARASITIC ACTIVITY; ARTICLE; CHAGAS DISEASE; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; DRUG SENSITIVITY; DRUG STRUCTURE; ELECTRON SPIN RESONANCE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; K NEAREST NEIGHBOR; NONHUMAN; OXIDATIVE STRESS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; TAUTOMERIZATION; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; WORLD HEALTH ORGANIZATION; ANIMAL; DRUG EFFECT; PARASITOLOGY; REVIEW; SYNTHESIS;

ANIMALS; CHAGAS DISEASE; HETEROCYCLIC COMPOUNDS; HUMANS; NITRO COMPOUNDS; ORGANOMETALLIC COMPOUNDS; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 58149377783     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955708786369528     Document Type: Article

References (88)

1. De Souza, W. Basic cell biology of Trypanosoma cruzi. Curr. Pharm. Des., 2002, 4, 269-85.
2. http://www.who.int/ctd/chagas.
3. Grant, I.H.; Gold, J.W.M.; Wittner, M.; Tanowitz, H.B.; Nathan, C.; Mayer, K.; Reich, L.; Wollner, N.; Steinherz, L.; Ghavimi, F.; O'Reilly, R.J.; Armstrong, D. Transfusion-associated acute Chagas disease acquired in the United States. Ann. Intern. Med., 1989, 111, 849-51.
4. Hagar, J.M.; Rahimtoola, S.H. N. Chagas' heart disease in the United States. Engl. J. Med., 1991, 325, 763-8.
5. Leiby, D.A.; Read, E.J.; Lenes, B.A.; Yun, A.J.; Stumf, R.J.; Kirchhoff, L.V.; Dodd, R.Y. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors. J. Infect. Dis., 1997, 176, 1047-52.
6. Bestetti, R. B.; Muccillo, G. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int. J. Cardiol., 1997, 60, 187-93.
7. Rassi, A.; Rassi, A.; Little, W.C. Chagas' heart disease. Clin. Cardiol., 2000, 23, 883-9.
8. Tarleton, R. L.; Zhang, L. Chagas disease etiology: autoimmunity or parasite persistence? Parasitol. Today, 1999, 15, 94-9.
9. Girones, N.; Fresno, M. Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? Trends Parasitol., 2003, 19, 19-22.
10. Schofield, C.J.; Dias, J.C. The Southern Cone Initiative against Chagas disease. Adv. Parasitol., 1999, 42, 1-27.
11. Dias, J.C.; Silveira, A.C.; Schofield, C.J. The impact of Chagas disease control in Latin America: a review. Mem. Inst. Oswaldo Cruz, 2002, 97, 603-12.
12. Cerecetto, H.; González, M. Chemotherapy of Chagas' disease: status and new developments. Curr. Topics Med. Chem., 2002, 2, 1185-213.
13. Cerecetto, H.; Di Maio, R.; Ibarruri, G.; Seoane, G.; Denicola, A.; Quijano, C.; Peluffo, G.; Paulino, M. Synthesis and antitrypanosomal activity of novel 5-nitro-2-furaldehyde and 5-nitrothiophene-2-carboxaldehyde semicarbazone derivatives. Farmaco, 1998, 53, 89-94.
14. Cerecetto, H.; Di Maio, R.; González, M.; Risso, M.; Sagrera, G.; Seoane, G.; Denicola, A.; Peluffo, G.; Quijano, C.; Stoppani, A.O.M.; Paulino, M.; Olea-Azar, C.; Basombrio, M.A. Synthesis and ntitrypanosomal evaluation of E-isomers of 5-nitro-2-furaldehyde and 5-nitrothiophene-2-carboxaldehyde semicarbazone derivatives. structure-activity relationships. Eur. J. Med. Chem., 2000, 35, 343-50.
15. Olea-Azar, C.; Atria, A.M.; Mendizabal, F.; Di Maio, R.; Seoane, G.; Cerecetto, H. Cyclic voltammetry and electron paramagnetic resonance studies of some analogues of Nifurtimox. Spect. Lett., 1998, 31, 99-109.
16. Olea-Azar, C.; Atria, A.M.; Di Maio, R.; Seoane, G.; Cerecetto, H. Electron spin resonance and cyclic voltammetry studies of nitrofu-rane and nitrothiophene analogues of Nifurtimox. Spect. Lett., 1998, 31, 849-57.
17. Martínez-Merino, V.; Cerecetto, H. CoMFA-SIMCA model for antichagasic Nitrofurazone derivatives Bioorg. Med. Chem., 2001, 9, 1025-30.
18. Paulino, M.; Iribarne, F.; Hansz, M.; Vega, M.; Seoane, G.; Cerecetto, H.; Di Maio, R.; Caracelli, I.; Zukerman-Schpector, J.; Olea, C.; Stoppani, O.A.M.; Berriman, M.; Fairlamb, A.H.; Tapia. Computer assisted design of potentially active anti-trypanosomal compounds. J. Mol. Struct. (Theochem), 2002, 584, 95-105.
19. Olea-Azar, C.; Rigol, C.; Opazo, L.; Morello, A.; Maya, J.D.; Repetto, Y., Aguirre, G.; Cerecetto, H.; Di Maio, R.; González, M.; Porcal, W. ESR and spin trapping studies of two new potential antitrypanosomal drugs. J. Chil. Chem. Soc., 2003, 48, 77-9.
20. Aguirre, G.; Cabrera, E.; Cerecetto, H.; Di Maio, R.; González, M.; Seoane, G.; Duffaut, A.; Denicola, A.; Gil, M.J.; Martínez-Merino, V. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design. Eur. J. Med. Chem., 2004, 39, 421-31.
21. Aguirre, G.; Boiani, M.; Cabrera, E.; Cerecetto, H.; Di Maio, R.; González, M.; Denicola, A.; Sant’Anna, C.M.R.; Barreiro, E. New potent 5-nitrofuryl derivatives as inhibitors of Trypanosoma cruzi growth. 3D-QSAR (CoMFA) studies. Eur. J. Med. Chem., 2006, 41, 457-66.
22. Greenbaum, D.C.; Mackey, Z.; Hansell, E.; Doyle, P.; Gut, J.; Caffrey, C.R.; Lehrman, J.; Rosenthal, P.J.; McKerrow, J.H.; Chibale, K. Synthesis and structure-activity relationships of para-siticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi. J. Med. Chem., 2004, 47, 3212-9.
23. Siles, R.; Chen, S.E.; Zhou, M.; Pinney, K.G.; Trawick, M.L. Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas' disease. Bioorg. Med. Chem. Lett., 2006, 16, 4405-9.
24. Aguirre, G.; Cerecetto, H.; González, M.; Gambino, D.; Otero, L.; Olea-Azar, C.; Rigol, C.; Denicola, A. In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones. Bioorg. Med. Chem., 2004, 12, 4885-93.
25. Otero, L.; Maya, J.D.; Morello, A.; Rigol, C.; Barriga, G.; Rodríguez, J.; Folch, C.; Norambuena, E.; González, M.; Olea Azar, C.; Cerecetto, H.; Gambino, G. Insight into the bioreductive mode of action of antitrypanosomal 5-nitrofuryl containing thiosemicarbazones. Med. Chem., 2008, 4, 11-7.
26. Olea-Azar, C.; Rigol, C.; Mendizabal, F.; Morello, A.; Maya, J.D.; Moncada, C.; Cabrera, E.; Di Maio, R.; González, M.; Cerecetto, H. ESR spin trapping studies of free radicals generated from nitrofuran derivatives analogues of Nifurtimox by electrochemical and Trypanosoma cruzi reduction. Free Radic. Res., 2003, 37, 993-1001.
27. Gerpe, A.; Odreman-Nuñez, I.; Draper, P.; Boiani, L.; Urbina, J.A.; González, M.; Cerecetto, H. Heteroallyl-containing 5-nitrofuranes as new anti-Trypanosoma cruzi agents with a dual mechanism of action. Bioorg. Med. Chem., 2008, 16, 569-77.
28. Cerecetto, H.; Di Maio, R.; González, M.; Seoane, G. Preparation of enamines from the condensation of glycine esters with nitro-heterocyclic aldehydes. Heterocycles, 1997, 45, 2023-31.
29. Iribarne, F.; González, M.; Cerecetto, H.; Aguilera, S.; Tapia, O.; Paulino, M. Interaction energies of nitrofurans with trypanothione reductase and glutathione reductase studied by molecular docking. J. Mol. Struct. (Theochem), 2007, 818, 7-22.
30. Di Maio, R.; Cerecetto, H.; Seoane, G.; Ochoa, C.; Arán, V.J.; Pérez, E.; Gómez-Barrio, A.; Muelas, S. Synthesis and antichagasic properties of new 1,2,6-thiadiazin-3,5-dione 1,1-dioxides and related compounds. Arzneim. Forsch. (Drug Res.), 1999, 49, 759-63.
31. Muelas, S.; Di Maio, R.; Cerecetto, H.; Seoane, G.; Ochoa, C.; Escario, J.A.; Gómez-Barrio, A. New thiadiazine derivatives with activity against Trypanosoma cruzi amastigotes. Folia Parasitol., 2001, 48, 105-8.
32. Albini, A.; Pietra, A. Heterocyclic N-oxides, CRC Press: Boston, 1991.
33. Cerecetto, H.; González, M. In Topics in Heterocyclic Chemistry; Mahmud T.H. Khan, Ed.; Springer: Berlin, 2007; Vol. 10, pp. 265-308.
34. González, M.; Cerecetto, H., Monge, A. In Topics in Heterocyclic Chemistry; Mahmud T.H. Khan, Ed.; Springer: Berlin, 2007; Vol. 11, 179-211.
35. Henderson, G.B.; Ulrich, P.; Fairlamb, A.H.; Rosenberg, I.; Pereira, M.; Sela, M.; Cerami, A. "Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease. Proc. Natl. Acad. Sci. USA, 1988, 85, 5374-8.
36. Hunter, W.N.; Bailey, S.; Habash, J.; Harrop, S.J.; Helliwell, J.R.; Aboyage-Kwarteng, T.; Smith, K.; Fairlamb, A.H. Active site of trypanothione reductase. A target for rational drug design. J. Mol. Biol., 1992, 227, 322-33.
37. Chan, C.; Yin, H.; Garforth, J.; McKie, J.H.; Jaouhari, R.; Speers, P.; Douglas, K.T.; Rock, P.J.; Yardley, V.; Croft, S.L.; Fairlamb, A.H. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs. J. Med. Chem., 1998, 41, 148-56.
38. Cerecetto, H.; Di Maio, R.; González, M.; Risso, M.; Saénz, P.; Seoane, G.; Denicola, A.; Peluffo, G.; Quijano, C.; Olea-Azar, C. 1,2,5-Oxadiazole N-oxide derivatives and related compounds as potential antitrypanosomal drugs: structure-activity relationships. J. Med. Chem., 1999, 42, 1941-50.
39. Medana, C.; Ermondi, G.; Fruttero, R.; Di Stilo, A.; Ferretti, C.; Gasco, A. Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation. J. Med. Chem., 1994, 37, 4412-6.
40. Galli, U.; Lazzarato, L.; Bertinaria, M.; Sorba, G.; Gasco, A.; Parapini, S.; Taramelli, D. Synthesis and antimalarial activities of some furoxan sulfones and related furazans. Eur. J. Med. Chem., 2005, 40, 1335-40.
41. Boiani, L.; Aguirre, G.; González, M.; Cerecetto, H.; Chidichimo, A.; Cazzulo, J.J.; Bertinaria, M.; Guglielmo, S. Furoxan-, alkylni-trate-derivatives and related compounds as anti-trypanosomatid agents: Mechanism of action studies. Bioorg. Med. Chem., 2008, 16, 7900-7.
42. Olea-Azar, C.; Rigol, C.; Mendizabal, F.; Briones, R.; Cerecetto, H.; Di Maio, R.; González, M.; Porcal, W.; Risso, M. Electrochemical and microsomal production of free radicals from 1,2,5-oxadiazole N-oxide as potential antiprotozoal drugs. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2003, 59, 69-74.
43. Aguirre, G.; Cerecetto, H.; Di Maio, R.; González, M.; Porcal, W.; Seoane, G.; Ortega, M.A.; Aldana, I.; Monge, A.; Denicola, A. Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Structure-activity relationships. Part II. Arch. Pharm., 2002, 335, 15-21.
44. Hansch, C.; Leo, A. Substituent Constants for Correlation Analysis in Chemistry and Biology, Wiley: New York, 1979.
45. Aguirre, G.; Boiani, L.; Cerecetto, H.; Di Maio, R.; González, M.; Porcal, W.; Thomson, L.; Tórtora, V.; Denicola, A.; Möller, M. Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Part III. Substituents-clustering methodology in the search of new active compounds. Bioorg. Med. Chem., 2005, 13, 6324-35.
46. Aguirre, G.; Boiani, L.; Boiani, M.; Cerecetto, H.; Di Maio, R.; González, M.; Porcal, W.; Denicola, A.; Piro, O.E.; Castellano, E.E.; Sant’Anna, C.M.R.; Barreiro, E.J. New potent 5-substituted benzofuroxans as inhibitors of Trypanosoma cruzi growth. Quantitative structure-activity relationship studies. Bioorg. Med. Chem., 2005, 13, 6336-46.
47. 2+). Farmaco, 2001, 56, 799-802.
48. Olea-Azar, C.; Rigol, C.; Mendizábal, F.; Cerecetto, H.; Di Maio, R.; González, M.; Porcal, W.; Morello, A.; Repetto, Y.; Maya, J.D. Novel benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as antichagasic agents: Chemical and biological studies. Lett. Drug Des. Dis., 2005, 2, 294-301.
49. Porcal, W.; Hernández, P.; Aguirre, G.; Boiani, L.; Boiani, M.; Merlino, A.; Ferreira, A.; Di Maio, R.; Castro, A.; González, M.; Cerecetto, H. Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: Synthesis, biological evaluation, and structure-activity relationships. Bioorg. Med. Chem., 2007, 15, 2768-81.
50. Porcal, W.; Merlino, A.; Boiani, M.; Gerpe, A.; González, M.; Cerecetto, H. Arylethenylbenzofuroxan derivatives as drugs for Chagas disease: Multigram batch synthesis using a Wittig-Boden process. Org. Process Res. Dev., 2008, 12, 156-62.
51. Gerpe, A.; Merlino, A.; Boiani, M.; Porcal, W.; Fagiolino, P.; González, M.; Cerecetto, H. Development of a HPLC method for the determination of antichagasic phenylethenylbenzofu-roxans and its major synthetic secondary products in the chemical production processes. J. Pharm. Biomed. Anal., 2008, 47, 88-94.
52. Boiani, L.; Davies, C.; Arredondo, C.; Porcal, W.; Merlino, A.; Gerpe, A.; Boiani, M.; Pacheco, J.P.; Basombrío, M.A.; Cerecetto, H.; González, M. In vivo studies of 5-arylethenylbenzofuroxans in acute murine models of Chagas' disease. Eur. J. Med. Chem., 2008.
53. Porcal, W.; Hernández, P.; Boiani, M.; Aguirre, G.; Boiani, L.; Chidichimo, A.; Cazzulo, J.J.; Campillo, N.E.; Paez, J.A.; Castro, A.; Krauth-Siegel, R.L.; Davies, C.; Basombrío, M.A.; González, M.; Cerecetto, H. In vivo anti-Chagas vinylthio-, vinylsulfinyl-and vinylsulfonyl-benzofuroxan derivatives. J. Med. Chem., 2007, 50, 6004-15.
54. Aguirre, G.; Cerecetto, H.; Di Maio, R.; González, M.; Alfaro, M.E.; Jaso, A.; Zarranz, B.; Ortega, M.A.; Aldana, I.; Monge-Vega, A. Quinoxaline N,N’-dioxide derivatives and related com-pounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships. Bioorg. Med. Chem. Lett., 2004, 14, 3835-9.
55. Lavaggi, M.L.; Aguirre, G.; Boiani, L.; Orelli, L.; García, B.; Cerecetto, H.; González, M. Pyrimido[1,2-a]quinoxaline 6-oxide and phenazine 5,10-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Eur. J. Med. Chem., 2008, 43, 1737-41.
56. Cerecetto, H.; González, M.; Lavaggi, M.L.; Azqueta, A.; Ezpeleta, O.; López de Cerain, A.; Monge-Vega, A. Phenazine 5,10-dioxide derivatives as hypoxic selective cytotoxins. J. Med. Chem., 2005, 48, 21-3.
57. 10-dioxides. Effects of benzofuroxan substituents in the outcome of their expansion reaction with phe-nolates. J. Braz. Chem. Soc., 2005, 16, 1290-6.
58. Cerecetto, H.; González, M.; Lavaggi, M.L.; Aravena, M.A.; Rigol, C.; Olea-Azar, C.; Azqueta, A.; López de Ceráin, A.; Monge, A.; Bruno, A.M. Phenazine 5,10-dioxide derivatives as hypoxic selective cytotoxins. Part II. Structure-activity relationship studies. Med. Chem., 2006, 2, 511-21.
59. Aguirre, G.; Boiani, M.; Cerecetto, H.; Gerpe, A.; González, M., Fernández Sainz, Y.; Denicola, A.; Ochoa de Ocáriz, C.; Nogal, J.J.; Montero, D.; Escario, J.A. Novel antiprotozoal products: Imidazole and benzimidazole N-oxide derivatives and related compounds. Arch. Pharm., 2004, 337, 259-70.
60. Boiani, M.; Boiani, L.; Denicola, A.; Torres de Ortiz, S.; Serna, E.; Vera de Bilbao, N.; Sanabria, L.; Yaluff, G.; Nakayama, H., Rojas de Arias, A.; Vega, C.; Rolan, M.; Gómez-Barrio, A.; Cerecetto, H.; González, M. 2H-Benzimidazole 1,3-dioxide derivatives: A new family of water-soluble anti-trypanosomatid. J. Med. Chem., 2006, 49, 3215-20.
61. Boiani, M.; Cerecetto, H.; González, M.; Piro, O.E.; Castellano, E.E. Tautomerism and reactivity in heterocycles N-oxides: A spectroscopic and theoretical study of benzimidazole N-oxide derivatives (N-hydroxybenzimidazoles). J. Phys. Chem. Part A, 2004, 108, 11241-8.
62. Merlino, A.; Boiani, M.; Cerecetto, H.; González, M. 2-Benzyl-2-methyl-2H-benzimidazole 1,3-dioxide derivatives: Spectroscopic and theoretical study. Spectrochim. Acta Part A. Mol. Biomol. Spectrosc., 2007, 67, 540-9.
63. 3-oxide. Synthesis, 2004, 16, 2678-84.
64. 3-oxide rearrangement. Lett. Org. Chem., 2005, 2, 501-6.
65. 9-bis(glutathionyl)aminopropylcadaverine (homotrypanothione) in Trypanosoma cruzi. Eur. J. Biochem., 1994, 226, 1019-27.
66. Caterina, M.C.; Perillo, I.A.; Boiani, L.; Pezaroglo, H.; Cerecetto, H.; González, M.; Salerno, A. Imidazolidines as new anti-Trypanosoma cruzi agents: Biological evaluation and structure-activity relationships. Bioorg. Med. Chem., 2008, 16, 2226-34.
67. Gerpe, A.; Aguirre, G.; Boiani, L.; Cerecetto, H.; González, M.; Olea-Azar, C.; Rigol, C.; Maya, J.D.; Morello, A.; Piro, O.E.; Arán, V.J.; Azqueta, A.; López de Ceráin, A.L.; Monge, A.; Rojas, M.A.; Yaluff, G. Indazole N-oxide derivatives as antiprotozoa agents. Synthesis, biological evaluation and QSAR studies. Bioorg. Med. Chem., 2006, 14, 3467-80.
68. Arán, V.J.; Ochoa de Ocáriz, C.; Boiani, L.; Buccino, P.; Cerecetto, H.; Gerpe, A.; González, M.; Montero, D.; Nogal, J.J.; Gómez-Barrio, A.; Azqueta, A.; López de Ceráin, A.; Piro, O.E.; Castellano, E.E. Synthesis and biological properties of new 5-nitroindazole derivatives. Bioorg. Med. Chem., 2005, 13, 3197-207.
69. Olea-Azar, C.; Cerecetto, H.; Gerpe, A.; González, M.; Arán, V.J.; Rigol, C.; Opazo, L. ESR and electrochemical study of 5-nitroindazole derivatives with antiprotozoal activity. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2006, 63, 36-42.
70. Rodríguez, J.; Olea-Azar, C.; Barriga, G.; Folch, C.; Gerpe, A.; Cerecetto, H.; González, M. Comparative spectroscopic and electrochemical study of nitroindazoles: 3-Alcoxy, 3-hydroxy and 3-oxo derivatives. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2008, 70, 557-63.
71. Boiani, M.; Cerecetto, H.; González, M.; Gasteiger, J. Modeling anti-Trypanosoma cruzi activity of N-oxide containing heterocycles. J. Chem. Inf. Model., 2008, 48, 213-9.
72. Sánchez-Delgado, R. A.; Anzellotti, A. Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis. Mini-Rev. Med. Chem., 2004, 4, 23-30.
73. Farrell, N. P. Transition Metal Complexes as Drugs and Chemotherapeutic Agents, Kluwer Academic Publishers: London, 1989.
74. 3)(3-(5-nitrofuryl)acroleine semicarbazone]. Anorg. Allg. Chem., 2003, 629, 1033-8.
75. Otero, L.; Noblia, P.; Gambino, D.; Cerecetto, H.; González, M.; Di Maio, R.; Ellena, J.; Piro, O.E. Synthesis and characterization of new ruthenium complexes with active ligands against Chagas’ disease. Inorg. Chim. Acta, 2003, 344, 85-94.
76. Otero, L.; Aguirre, G.; Boiani, L.; Denicola, A.; Rigol, C.; Olea-Azar, C.; Maya, J.D.; Morello, A.; González, M.; Gambino, D.; Cerecetto, H. Nitrofurylsemicarbazone rhenium and ruthenium complexes as antitrypanosomal agents. Eur. J. Med. Chem., 2006, 41, 1231-9.
77. Otero, L.; Smircich, P.; Vieites, M.; Ciganda, M.; Cardoso Severino, P.; Terenzi, H., Cerecetto, H., Gambino, D.; Garat, B. DNA conformational changes and cleavage by ruthenium (II) nitrofurylsemicarbazone complexes. J. Inorg. Biochem., 2007, 101, 74-9.
78. Otero, L.; Vieites, M.; Boiani, L.; Denicola, A.; Rigol, C.; Opazo, L.; Olea-Azar, C.; Maya, J.D.; Morello, A.; Krauth-Siegel, R.L.; Piro, O.E.; Castellano, E.; González, M.; Gambino, D.; Cerecetto, H. Novel antitrypanosomal agents based on palladium nitrofuryl-thiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets. J. Med. Chem., 2006, 49, 3322-31.
79. Gambino, D.; Otero, L.; Vieites, M.; Boiani, M.; González, M.; Baran, E.J.; Cerecetto, H. Vibrational spectra of palladium 5-nitrofuryl thiosemicarbazone complexes: Experimental and theoretical study. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2007, 68, 341-8.
80. Otero, L.; Folch, C.; Barriga, G.; Rigol, C.; Opazo, L.; Vieites, M.; Gambino, D.; Cerecetto, H.; Norambuena, E.; Olea-Azar, C. ESR, electrochemical and reactivity studies of antitrypanosomal palladium thiosemicarbazone complexes. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2008, 70, 519-23.
81. Vieites, M.; Otero, L.; Santos, D.; Toloza, J.; Figueroa, R.; Norambuena, E.; Olea-Azar, C.; Aguirre, G.; Cerecetto, H.; González, M.; Morello, A.; Maya, J.D.; Garat, B.; Gambino, D. Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents. J. Inorg. Biochem., 2008, 102, 1033-43.
82. Noblía, P.; Vieites, M.; Torre, M.H.; Costa-Filho, A.J.; Cerecetto, H.; González, M.; Lavaggi, M.L.; Adachi, Y.; Sakurai, H.; Gambino, D. Novel vanadyl complexes with quinoxaline N(1), N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds. J. Inorg. Biochem., 2006, 100, 281-7.
83. Vieites, M.; Noblía, P.; Torre, M.H.; Cerecetto, H.; Lavaggi M.L.; Costa-Filho, A.J.; Azqueta, A.; López de Ceráin, A.; Monge, A.; Parajón-Costa, B.; González, M.; Gambino, D. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives. J. Inorg. Biochem., 2006, 100, 1358-67.
84. Docampo, R.; Moreno, S. N. J. The acidocalcisome. Mol. Biochem. Parasitol., 2001, 114, 151-9.
85. Urquiola, C.; Vieites, M.; Aguirre, G.; Marín, A.; Solano, B.; Ar-rambide, G.; Noblía, P.; Lavaggi, M.L.; Torre, M.H.; González, M.; Monge, A.; Gambino, D.; Cerecetto, H. Improving antitrypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium. Bioorg. Med. Chem., 2006, 14, 5503-9.
86. Turrens, J.F.; Newton, C.L.; Zhong, L.; Hernández, F.R.; Whitfield, J.; Docampo, R. Mercaptopyridine-N-oxide, an NADH-fumarate reductase inhibitor, blocks Trypanosoma cruzi growth in culture and in infected myoblasts. FEMS Microbiol. Lett., 1999, 175, 217-21.
87. Vieites, M.; Smircich, P.; Parajón-Costa, B.; Rodríguez, J.; Galaz, V.; Olea-Azar, C.; Otero, L.; Aguirre, G.; Cerecetto, H.; González, M.; Gómez-Barrio, A.; Garat, B.; Gambino, D. Potent in vitro anti-Trypanosoma cruzi activity of pyridine-2-thiol N-oxide metal complexes having an inhibitory effect on parasite-specific fumarate reductase. J. Biol. Inorg. Chem., 2008, 13, 723-35.
88. Pérez-Rebolledo, A.; Teixeira, L.R.; Batista, A.A.; Mangrich, A.S.; Aguirre, G.; Cerecetto, H.; González, M.; Hernández, P.; Ferreira, A.M.; Speziali, N.L.; Beraldo, H. 4-Nitroacetophenone-derived thiosemicarbazones and their copper(II) complexes with significant in vitro anti-trypanosomal activity. Eur. J. Med. Chem., 2008, 43, 939-48.